Avenda Health

Executive Summary

Avenda Health is a Los Angeles-based digital health company specializing in AI-powered prostate cancer management. Its flagship product, Unfold AI, is an FDA-cleared platform that generates 3D cancer estimation maps from standard clinical data, enabling precise diagnosis and personalized focal therapy planning. By integrating artificial intelligence into oncology workflows, Avenda Health aims to improve patient outcomes through more targeted treatments, reducing overtreatment and side effects associated with conventional whole-gland therapies. The company's technology addresses a significant unmet need in prostate cancer care, where accurate tumor localization is critical for optimizing treatment decisions. With a focus on commercializing its platform within urology and radiation oncology practices, Avenda Health is positioned to capture value in the growing precision oncology market. However, as a private company with limited disclosures on financials and adoption, its valuation and revenue traction remain opaque.

Upcoming Catalysts (preview)

• Q3 2026Expansion of FDA clearance to additional clinical indications70% success
• H2 2026Publication of clinical validation study in peer-reviewed journal80% success
• Q4 2026Strategic partnership with major urology group or hospital network60% success